April 1, 2021 11:06 AM EDTUpdated 11:38 AM

United Therapeutics bags a new OK on Tyvaso, with blockbuster expectations; Gilead goes back to AbCellera's well with a set of fresh targets

As expected, United Therapeutics {UTHR} snagged an OK from the FDA to sell the inhaled version of its blockbuster drug Tyvaso for a new indication …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Unit­ed Ther­a­peu­tics bags a new OK on Ty­va­so, with block­buster ex­pec­ta­tions; Gilead goes back to Ab­Celler­a's well with a set of fresh tar­gets